Results 91 to 100 of about 7,348 (201)

Mesalamine: Safe at first look [PDF]

Inflammatory Bowel Diseases, 1999
L J, Saubermann, J L, Wolf
openaire   +2 more sources

The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcerative Colitis [PDF]

, 2013
Brian G. Feagan, William J. Sandborn, Geert D’Haens, Suresh Pola, John WD McDonald, Paul Rutgeerts, Pia Munkholm, U. Mittmann, Debra King, Cindy J. Wong, Guangyong Zou, Allan Donner, Lisa M. Shackelton, D. Gilgen, Sigrid Nelson, Margaret K. Vandervoort, Marianne Fahmy, Edward V. Loftus, Remo Panaccione, Simon Travis, Gert A. Van Assche, Séverine Vermeire, Barrett G. Levesque   +22 more
openalex   +1 more source

New Dissolution Method for Mesalamine Tablets and Capsules

, 2008
Monica C. Chuong, J. Mark Christensen, James W. Ayres   +2 more
openalex   +1 more source

Mesalamine (5-ASA) for the prevention of recurrent diverticulitis [PDF]

, 2017
Flloyd Carter, Majd Alsayb, John K. Marshall, Yuhong Yuan   +3 more
openalex   +1 more source

Development and Optimization of RP-UHPLC Method for Mesalamine Through QbD Approach

, 2022
Diponkor Kumar Shill, Uttom Kumar, ASM Monjur Al Hossain, Md. Rezowanur Rahman, Abu Shara Shamsur Rouf   +4 more
openalex   +2 more sources

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice [PDF]

, 2021
David M. Alvarado, Juhee Son, Larissa B. Thackray, Michael Diamond, Siyuan Ding, Matthew A. Ciorba   +5 more
openalex   +1 more source

Mesalamine Induced Pneumonitis [PDF]

C37. CASE REPORTS IN DRUG INDUCED LUNG DISEASE, 2020
C. Rosse, B. Rai, C. Schmitt
openaire   +1 more source

High‐ and Low‐Dose Oral Delayed‐Release Mesalamine in Children With Mild‐to‐Moderately Active Ulcerative Colitis

, 2014
Harland S. Winter, Piotr Krzeski, Melvin B. Heyman, Eduardo Ibarguen‐Secchia, Barbara Iwańczak, M Kaczmarski, Jarosław Kierkuś, Sanja Kolaček, B. O. Osuntokun, J. Antonio Quiros, Manoj Shah, Bruce Yacyshyn, Preston Dunnmon   +12 more
openalex   +1 more source

Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis

Drug Design, Development and Therapy, 2016
Carmen Cuffari,1 David Pierce,2 Bartosz Korczowski,3 Krzysztof Fyderek,4 Heather Van Heusen,5 Stuart Hossack,6 Hong Wan,5 Alena YZ Edwards,7 Patrick Martin5 1Department of Pediatrics, Division of Pediatric Gastroenterology and Nutrition, The Johns ...
Cuffari C, Pierce D, Korczowski B, Fyderek K, Van Heusen H, Hossack S, Wan H, Edwards AY, Martin P   +8 more
doaj  

Real-World Adherence and Relapse Risk in Mesalamine Treatment for Ulcerative Colitis: Insights from a Large Japanese Medical Claims Database. [PDF]

Inflamm Intest Dis
Wada T, Hosomi S, Kobayashi Y, Nakata R, Nishida Y, Maruyama H, Ominami M, Nadatani Y, Fukunaga S, Otani K, Tanaka F, Fujiwara Y.   +11 more
europepmc   +1 more source